JP2007523111A - 虚血性組織の潅流を刺激するためのｘｉｉｉ因子の使用 - Google Patents

虚血性組織の潅流を刺激するためのｘｉｉｉ因子の使用 Download PDF

Info

Publication number
JP2007523111A
JP2007523111A JP2006553508A JP2006553508A JP2007523111A JP 2007523111 A JP2007523111 A JP 2007523111A JP 2006553508 A JP2006553508 A JP 2006553508A JP 2006553508 A JP2006553508 A JP 2006553508A JP 2007523111 A JP2007523111 A JP 2007523111A
Authority
JP
Japan
Prior art keywords
factor xiii
treated
preparation
activated
mice
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006553508A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007523111A5 (https=
Inventor
アイーダ・インバル
リマ・ダーディク
ジョナサン・レオール
ゲーアハルト・ディクナイテ
Original Assignee
ツェー・エス・エル・ベーリング・ゲー・エム・ベー・ハー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ツェー・エス・エル・ベーリング・ゲー・エム・ベー・ハー filed Critical ツェー・エス・エル・ベーリング・ゲー・エム・ベー・ハー
Publication of JP2007523111A publication Critical patent/JP2007523111A/ja
Publication of JP2007523111A5 publication Critical patent/JP2007523111A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/45—Transferases (2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
JP2006553508A 2004-02-20 2005-02-15 虚血性組織の潅流を刺激するためのｘｉｉｉ因子の使用 Pending JP2007523111A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04003950A EP1566183A1 (en) 2004-02-20 2004-02-20 Use of factor XIII for stimulating the perfusion of ischemic tissue
PCT/EP2005/001495 WO2005079839A1 (en) 2004-02-20 2005-02-15 Use of factor xiii for stimulating the perfusion of ischemic tissue

Publications (2)

Publication Number Publication Date
JP2007523111A true JP2007523111A (ja) 2007-08-16
JP2007523111A5 JP2007523111A5 (https=) 2008-04-03

Family

ID=34707356

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006553508A Pending JP2007523111A (ja) 2004-02-20 2005-02-15 虚血性組織の潅流を刺激するためのｘｉｉｉ因子の使用

Country Status (11)

Country Link
US (1) US20070167361A1 (https=)
EP (2) EP1566183A1 (https=)
JP (1) JP2007523111A (https=)
KR (1) KR20060123567A (https=)
AT (1) ATE429244T1 (https=)
AU (1) AU2005215114B2 (https=)
CA (1) CA2556805C (https=)
DE (1) DE602005014085D1 (https=)
DK (1) DK1718328T3 (https=)
ES (1) ES2325996T3 (https=)
WO (1) WO2005079839A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITTO20130532A1 (it) * 2013-06-27 2014-12-28 Donato Gemmati Nuovo biomarcatore prognostico nell'infarto acuto del miocardio

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998051333A1 (en) * 1997-05-14 1998-11-19 Zymogenetics, Inc. Use of factor xiii for the manufacture of a medicament for the treatment of reperfusion injury and mucosal damage

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69431430T2 (de) * 1993-03-30 2003-05-22 Hoechst Japan Ltd., Tokio/Tokyo Faktor XIII zur Behandlung von Hautwunden
EP1572168B1 (en) * 2002-02-06 2010-05-26 Vicor Technologies, Inc. Anti-infarction molecules

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998051333A1 (en) * 1997-05-14 1998-11-19 Zymogenetics, Inc. Use of factor xiii for the manufacture of a medicament for the treatment of reperfusion injury and mucosal damage

Also Published As

Publication number Publication date
ATE429244T1 (de) 2009-05-15
CA2556805C (en) 2013-04-02
KR20060123567A (ko) 2006-12-01
EP1718328A1 (en) 2006-11-08
AU2005215114B2 (en) 2010-05-20
EP1566183A1 (en) 2005-08-24
DK1718328T3 (da) 2009-07-27
WO2005079839A1 (en) 2005-09-01
DE602005014085D1 (de) 2009-06-04
US20070167361A1 (en) 2007-07-19
EP1718328B1 (en) 2009-04-22
ES2325996T3 (es) 2009-09-28
AU2005215114A1 (en) 2005-09-01
CA2556805A1 (en) 2005-09-01

Similar Documents

Publication Publication Date Title
US20070093748A1 (en) Methods and systems for treating injured cardiac tissue
AU2003255290A1 (en) Use of erythropoietin
KR20090092325A (ko) Ｆｖⅲ 농축물을 포함하는 프로트롬빈 복합물 농축물의 상승적 치료 용도
JP6162759B2 (ja) ペプチドを有効成分とする血管関連疾患の治療剤組成物
US20100280493A1 (en) Methods and Systems for Treating Injured Cardiac Tissue
JP5400006B2 (ja) 虚血性疾患の予防または治療剤
JP3012319B2 (ja) 脳及び筋肉組織傷害による浮腫の治療剤
WO1993008821A1 (fr) Inhibiteur des effets secondaires dans la therapie du cancer
US6060449A (en) Neovascularization inhibitor containing tissue factor pathway inhibitor
JPWO1997035609A1 (ja) 組織因子凝固系インヒビター含有血管新生阻害剤
Kwaan et al. Localization of fibrinolytic activity in myocardial infarcts in rats
JP2007523111A (ja) 虚血性組織の潅流を刺激するためのｘｉｉｉ因子の使用
JP2009530411A (ja) 損傷心臓組織治療の方法と方式
US8106009B2 (en) Pharmaceutical composition for preventing or treating ischemic diseases
AU2003200309B2 (en) Pharmaceutical Composition for Preventing or Treating Ischaemic Diseases
CA1319610C (en) Method for inducing endogenous production of tissue plasminogen activator (tpa)
JPH09151137A (ja) 平滑筋細胞増殖抑制剤
JPWO2006025276A1 (ja) ナットウキナーゼを含む眼科疾患の治療・予防剤
US20240091306A1 (en) Peptides endowed with angiogenic activity
JPWO1999016463A1 (ja) 虚血性疾患の予防または治療剤
JP2003212792A (ja) 新規な血管新生促進剤
JPH0495031A (ja) 血栓溶解活性増強剤

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20080208

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20080208

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20110322

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20110622

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20110629

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20110920

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20120214